UnitedHealthcare
Tepmetko (tepotinib)
Drugs for Cancer : Drugs for Cancer
  • Prior Authorization: NSCLC cMET Mutation:
    Documented Diagnosis: Yes
    Duration: 12 Month(s)

  • NSCLC cMET Mutation:
    Duration: 12 Month(s)
    Documented Diagnosis: Yes
    Medical Test Required: No
    Reauthorization Required: No
    Duration of Reauthorization: N/A

  • Orally administered anticancer medication.
  • Quantity Limit: limit maximum 2 EA PER 1 day(s)